Miconazole 3 combination pack and Vulvovaginal swelling - a phase IV clinical study of FDA data

Summary:

Vulvovaginal swelling is reported as a side effect among people who take Miconazole 3 combination pack (miconazole nitrate), especially for people who are 20-29 old, have been taking the drug for < 1 month also take Armour Thyroid, and have Vulvovaginal mycotic infection.

The phase IV clinical study analyzes which people have Vulvovaginal swelling when taking Miconazole 3 combination pack. It is created by eHealthMe based on reports of 660 people who have side effects when taking Miconazole 3 combination pack from the FDA, and is updated regularly.

What is Miconazole 3 combination pack?

Miconazole 3 combination pack has active ingredients of miconazole nitrate. eHealthMe is studying from 662 Miconazole 3 combination pack users. Check the latest studies of Miconazole 3 combination pack.

What is Vulvovaginal swelling?

Vulvovaginal swelling is found to be associated with 87 drugs and 226 conditions by eHealthMe. Check the latest studies of Vulvovaginal swelling.

On Jul, 06, 2026

660 people reported to have side effects when taking Miconazole 3 combination pack.
Among them, 38 people (5.76%) have Vulvovaginal swelling.

Could Miconazole 3 combination pack cause Vulvovaginal swelling?

Among these 38 people:

How long have people been on Miconazole 3 combination pack when they have Vulvovaginal swelling? *

What is the age of people who have Vulvovaginal swelling when taking Miconazole 3 combination pack? *

What are other drugs people take besides Miconazole 3 combination pack? *

What are other side effects people have besides Vulvovaginal swelling? *

Vulvovaginal Burning Sensation: 24 people, 63.16%
Vulvovaginal Pain: 13 people, 34.21%
Vulvovaginal Pruritus (vulvovaginal severe itching): 9 people, 23.68%
Vulvovaginal Erythema (redness of the skin of vulva and vagina): 7 people, 18.42%
Hypersensitivity: 5 people, 13.16%
Vulvovaginal Discomfort: 4 people, 10.53%
Rashes (redness): 3 people, 7.89%
Abdominal Distension: 2 people, 5.26%
Fever: 2 people, 5.26%
Pain: 2 people, 5.26%

What are the existing conditions these people have? *

Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 24 people, 63.16%
Vulvovaginal Pruritus (vulvovaginal severe itching): 5 people, 13.16%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 7.89%
Vulvovaginal Burning Sensation: 3 people, 7.89%
High Blood Pressure: 3 people, 7.89%
Vulvovaginal Discomfort: 2 people, 5.26%
Birth Control: 2 people, 5.26%
Seasonal Allergy (allergic condition due to certain season): 2 people, 5.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.26%
High Blood Cholesterol: 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Miconazole 3 combination pack and have Vulvovaginal swelling?

- Check whether Vulvovaginal swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Miconazole 3 combination pack:

Miconazole 3 combination pack (662 reports)

Browse all side effects of Miconazole 3 combination pack:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vulvovaginal swelling:

Vulvovaginal swelling (87 drugs)

Browse all the conditions that are associated with Vulvovaginal swelling:

Vulvovaginal swelling (226 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on miconazole nitrate (the active ingredients of Miconazole 3 combination pack) and Miconazole 3 combination pack (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.